Earnings call transcript: Enovix beats Q2 2025 revenue forecast, stock rises

Enovix Corp. (ENVX) reported robust Q2 2025 results, with revenue of $7.5 million significantly exceeding the $5.57 million forecast and a narrower-than-expected EPS loss of -$0.13, alongside an improved gross margin of 31%. This performance, coupled with the launch of its high-energy-density A1 battery platform now undergoing qualification with major smartphone OEMs and AR/VR customers, drove a 1.63% premarket stock increase. The company authorized a $60 million share buyback and anticipates sequential revenue growth, with potential smartphone battery production by late 2024, positioning it to address the growing demand for advanced battery solutions in consumer electronics.

Analysis

Enovix Corp. delivered a significant Q2 2025 earnings beat, with revenue of $7.5 million surpassing forecasts by 34.65% and growing 98% year-over-year. The narrower-than-expected loss per share of -$0.13 was supported by a 5% YoY reduction in operating expenses and a strong gross margin of 31%, which management attributed to a favorable defense product mix. Strategically, the company has advanced to a critical commercialization phase, with its newly launched A1 high-energy-density battery platform now undergoing a multi-month qualification process with two major smartphone OEMs and a leading eyewear customer. Production of these batteries has commenced at its Fab 2 facility in Malaysia, and the company is funding further expansion via a warrant dividend, alongside authorizing a $60 million share buyback. While Q3 guidance anticipates continued sequential revenue growth, it also projects a slightly higher net operating loss due to a less favorable product mix and increased manufacturing readiness costs, highlighting that achieving sustained profitability through efficient mass production is the next major hurdle following these operational milestones.

Key Decisions for Investors

• Investors should closely monitor communications regarding the customer qualification status of the A1 battery platform, as confirmed purchase orders from the smartphone and eyewear OEMs currently testing the technology represent the most significant near-term valuation catalyst.
• While the Q2 results were strong, the guidance for a higher Q3 operating loss and commentary on manufacturing complexities underscore the critical execution risk ahead; focus should be on the company's ability to scale production efficiently and manage costs during this ramp-up phase.
• Given the stock's high beta of 2.08 and the ongoing need for capital to fund Fab 2 expansion, investors should consider the risk profile and potential for share dilution from warrant exercises, weighing it against the significant long-term growth potential if commercialization succeeds.